Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

This study has been completed.

Study NCT00083668 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: May 27, 2004 Last Updated: July 31, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2005
Estimated Primary Completion Date:	No date given